Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

PUREMED ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   11.4% 11.0% 8.8% 5.7% 6.4% 5.0% 12.4% 12.4%   Credit score (0-100)   22 23 28 39 36 43 19 19   Credit rating   BB BB BB BBB BBB BBB BB BB   Credit limit (kDKK)   -0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   827 952 1,251 818 978 1,336 0.0 0.0   EBITDA   -263 50.9 579 144 83.8 278 0.0 0.0   EBIT   -263 50.9 579 144 83.8 278 0.0 0.0   Pre-tax profit (PTP)   -287.7 22.1 564.2 143.9 83.8 269.5 0.0 0.0   Net earnings   -287.7 22.1 564.2 113.0 66.2 213.0 0.0 0.0   Pre-tax profit without non-rec. items   -288 22.1 564 144 83.8 269 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -133 -111 453 416 435 677 502 502   Interest-bearing liabilities   645 333 28.3 156 304 171 0.0 0.0   Balance sheet total (assets)   942 558 675 746 972 1,193 502 502   Net Debt   625 329 -104 -191 51.1 75.6 -502 -502     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   827 952 1,251 818 978 1,336 0.0 0.0   Gross profit growth   -23.6% 15.2% 31.3% -34.6% 19.5% 36.6% -100.0% 0.0%   Employees   2 2 1 0 1 1 0 0   Employee growth %   0.0% 0.0% -50.0% -100.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   -1,089.1 0.0 0.0 -635.8 0.0 0.0 0.0 0.0   Balance sheet total (assets)   942 558 675 746 972 1,193 502 502   Balance sheet change%   10.9% -40.7% 21.0% 10.5% 30.3% 22.7% -57.9% 0.0%   Added value   826.6 50.9 579.1 779.9 83.8 277.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -31.8% 5.3% 46.3% 17.6% 8.6% 20.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -27.3% 5.8% 86.1% 20.3% 9.8% 25.7% 0.0% 0.0%   ROI %   -49.5% 9.6% 129.0% 27.4% 12.8% 35.1% 0.0% 0.0%   ROE %   -52.5% 2.9% 111.6% 26.0% 15.6% 38.3% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   -12.4% -16.6% 67.1% 55.7% 44.7% 56.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -237.9% 646.8% -17.9% -132.5% 61.0% 27.2% 0.0% 0.0%   Gearing %   -483.1% -299.2% 6.3% 37.6% 69.9% 25.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.8% 5.9% 8.3% 0.3% 0.0% 3.9% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.8 0.7 1.6 1.5 1.2 0.9 0.0 0.0   Current Ratio   0.9 1.0 3.0 2.3 1.8 2.3 0.0 0.0   Cash and cash equivalent   20.3 4.3 132.1 347.3 252.8 95.0 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -133.5 -27.7 452.8 415.8 435.1 676.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   413 25 579 0 84 278 0 0   Employee expenses / employee   -545 0 0 0 0 0 0 0   EBITDA / employee   -131 25 579 0 84 278 0 0   EBIT / employee   -131 25 579 0 84 278 0 0   Net earnings / employee   -144 11 564 0 66 213 0 0